Interactions between epithelia and connective tissues play a major functional role dunrng embryogenesis. tissue repair and tumour growth (Bissel et al.. 1982; Bronner-Fraser. 1986; Korhonen et al.. 1990; Albelda. 1993) . More recently these interactions have been shown to be mediated mainly by the integrin superfamily of molecules ; Hemler, 1990; Hynes. 1992) . These heterodimeric transmembrane glycoproteins can modulate gene expression and differentiation by interacting with cytoskeletal components (Horvitz et al., 1986; Menko et al.. 1987; Werb et al., 1989; Adams et al., 1990; , thus acting as signal transducing molecules. Although a number of in vitro studies have extensively documented that malignant transformation results in qualitative as well as quantitative changes in integnn expression (Juliano et al.. 1993 ) a more complete appreciation of the biological relevance of integrins in tumour growth and metastasis requires in vivo analysis of autochthonous tumours. Malignant cutaneous melanoma is a human malignancy which, because of its development in well-defined stages (Clark et al., 1986 ) and its relative ease of propagation in culture (Herlyn et al., 1985) , offers the possibility of a critical comparison of in vitro and in situ integrin expression, Recent in vitro studies have demonstrated that fibronectin (FN) possesses mitogenic activity in melanoma cells and that this stimulus is mediated by the cx5,'P heterodimer (Mortanrni et al., 1993 (Figure la) , the former was frequently seen in metastatic melanoma ( Figure  lb and c) We show here that total FN is widely expressed in melanocytic lesions with no apparent relationship with transformation, tumour progression and metastatic phenotype. The evaluation of the FN-A and FN-B isoforms on the other hand has confirmed that their expression is enhanced by malignant transformation (Carnemolla et al.. 1989 ) and has demonstrated that only the FN-A variant is expressed in metastatic lesions. Although the biological basis of this differential expression of the two isoforms is presently unclear, the demonstration that melanoma cells can produce transforming growth factor beta (TGF-P) (Rodeck et al., 1994) , which has the ability to increase preferentially the expression of the FN-A isoform (BaLza et al., 1988) , may account for this finding. It is interesting in this context that increase in expression of the ED-A mRNA has been found to be closely associated with invasiveness of hepatocarcinomas (Oyama et al.. 1989) . The study of the third known FN isoform, the IIICS variant (Borsi et al., 1991) ).
In conclusion, the results of the present study have demonstrated that FN expression remains relatively stable but alternative RNA splicing is differently regulated during melanoma progression. This contrasts with other ECM glycoproteins which are modulated during melanoma progression (Natali et al., 1985 (Natali et al., , 1990 . Although this in vivo analysis cannot establish to what extent FN is derived by melanocyte cells, this lineage is known to have the ability to synthesise and release this macromolecule (McClenic et al., 1989) . Furthermore, the expression of a combination of highly promiscuous and specific integrin receptors suggests that the interactions with this ubiquitous ECM glycoprotein may, at least in part, account for the well-known property of this malignancy to metastasise to many anatomical sites (Rosai. 1981) .
Finally, in view of the ability of TGF-P to bind to FN (Fava and McClure, 1987) this ECM glycoprotein appears capable of modulating tumour growth by multiple mechanisms e.g. cell adhesion by interacting with various integrin receptors, direct mitogenic activity through selected integrin molecules, or growth control stimuli (Rodeck et al., 1994) through bound growth factors. Additional work using welldefined experimental models may eventually confirm this hypothesis.
